Myasthenia gravis (second of two parts).
D000109:Acetylcholine; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D001323:Autoantibodies / Q000032:analysis; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D003472:Curare; D004491:Edrophonium; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D051379:Mice; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology / Q000628:therapy; D011247:Pregnancy; D011950:Receptors, Cholinergic / Q000276:immunology; D013934:Thymectomy
D000305:Adrenal Cortex Hormones; D001323:Autoantibodies; D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic; D004491:Edrophonium; D003472:Curare; D000109:Acetylcholine